{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-23-000008","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2023-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.147540+00:00","generated_at":"2026-06-20T16:35:33.160290+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"Estab. Labs ready to submit PMA Module 4 for Motiva implants in Q1 2023; targets $500M revenue by FY2026","bullets":["Notified FDA it is ready to submit Module 4 of pre-market approval for Motiva Implants in the U.S.","Expects to file Module 4 during Q1 2023, working with FDA on optimal timing.","CEO to present at 41st J.P. Morgan Healthcare Conference on January 12, 2023.","Company targets $500 million in annual revenue for fiscal year 2026.","Presentation materials furnished as Exhibit 99.1; forward-looking statements noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-23-000008","json":"https://secwatch.observer/filing/0001688757-23-000008.json","markdown":"https://secwatch.observer/filing/0001688757-23-000008.md","text":"https://secwatch.observer/filing/0001688757-23-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000008/0001688757-23-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000008/esta-20230111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:35:33.160290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}